GlassScriptPhysician profile
Glenn D Babus
NPI 1700867413
$10,746.33
in general payments reported to CMS, 2019-2025
27 companies · $1,992 in 2025
The $1,992 reported for 2025 was more than what 82% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,660 · 2020: $1,363 · 2021: $1,698 · 2022: $1,245 · 2023: $333 · 2024: $456 · 2025: $1,992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619 · Travel and Lodging: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,619.19 |
| Travel and Lodging | $1,161.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,774.00 | 2019-2023 | Senza |
| Medtronic USA, INC. | $2,672.17 | 2019-2020 | |
| Medtronic, INC. | $2,142.75 | 2021-2025 | Venaseal, Intellis Adaptivestim, Synchromedii |
| Stratus Medical, LLC | $615.47 | 2020-2021 | |
| Si-Bone, INC. | $433.70 | 2019-2022 | |
| Stryker Corporation | $390.26 | 2020-2021 | |
| Boston Scientific Corporation | $373.07 | 2019-2021 | |
| Globus Medical, INC. | $220.58 | 2025 | Senza |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Spinal Elements, INC. | $128.85 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $127.36 | 2019 | |
| Surgalign Spine Technologies, INC. | $121.07 | 2022 | |
| Spine Wave, INC. | $110.27 | 2025 | Spinal Implant |
| Biotronik Nro, INC. | $99.67 | 2023 | Biotronik |
| Nuvasive, INC. | $98.93 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $70.37 | 2019 | |
| Collegium Pharmaceutical, INC. | $29.36 | 2019-2020 | |
| Eisai INC. | $24.10 | 2019 | |
| Flowonix Medical Incorporated | $20.44 | 2019 | |
| Kaleo, INC. | $19.69 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.69 | 2023 | Gammagard Liquid |
| Scilex Pharmaceuticals INC. | $18.04 | 2019 | |
| Pfizer INC. | $14.71 | 2019 | |
| Abbott Laboratories | $14.30 | 2020 | |
| Csl Behring | $13.46 | 2019 | |
| Biogen, INC. | $11.09 | 2019 | |
| Depuy Synthes Sales INC. | $2.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Babus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.